An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis. Clark MP, Leaman DW, Hazelhurst LA, Hwang ES, Quinn A Int Immunopharmacol. 2015 Dec 18; 31:74-87. PMID: 26709219. Abstract CommentRecommendBookmarkWatch